Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial.

MLA

Juul, Sandra E., et al. “Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial.” The Journal of Pediatrics, vol. 258, July 2023, p. 113400. EBSCOhost, https://doi.org/10.1016/j.jpeds.2023.113400.

APA

Juul, S. E., Comstock, B. A., Cornet, M.-C., Gonzalez, F. F., Mayock, D. E., Glass, H. C., Schreiber, M. D., Heagerty, P. J., & Wu, Y. W. (2023). Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial. The Journal of Pediatrics, 258, 113400. https://doi.org/10.1016/j.jpeds.2023.113400

Chicago

Juul, Sandra E, Bryan A Comstock, Marie-Coralie Cornet, Fernando F Gonzalez, Dennis E Mayock, Hannah C Glass, Michael D Schreiber, Patrick J Heagerty, and Yvonne W Wu. 2023. “Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial.” The Journal of Pediatrics 258 (July): 113400. doi:10.1016/j.jpeds.2023.113400.